Perspective Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +8.1% | +0.0% | +1.4% | +0.0% | +66.4% | +0.0% | +30.6% | +6.2% | +186.6% | +133.9% | +41.0% | |
| – | +17.9% | +0.0% | -22.0% | +0.0% | +181.6% | +0.0% | -25.8% | +66.5% | +178.1% | +44.1% | +66.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +763.9% | +989.5% | -94.7% | |
| – | -38.5% | +0.0% | +39.6% | +0.0% | -30.2% | +0.0% | +6.0% | +7.1% | +255.0% | +4,975.9% | -76.6% | |
| – | – | +0.0% | +42.9% | +0.0% | – | – | +10,107.0% | – | – | -998.3% | – | |
| – | +0.0% | +0.0% | -18.2% | +0.0% | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -29.4% | +8.3% | |
| – | -86.5% | +0.0% | +6,407.4% | +0.0% | -99.9% | +0.0% | -50.0% | +100.0% | +1,301.8% | +36,764.3% | -96.4% | |
| – | -207.6% | – | – | +0.0% | -112.9% | – | – | – | -6,558.8% | – | -159.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.